Most Recent
Pharmacor challenges patent extension for Biogen’s MS drug
Intellectual Property 2021-09-23 2:14 pm By Bianca Hrovat

An Australian generic drug manufacturer has struck back at patent lawsuit by Swiss pharmaceutical company Biogen, alleging a patent for MS drug Tecfidera is invalid and a that a patent term extension for the drug  was wrongly granted.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Cytec prevails again in challenge to Nalco mining patent
Energy & Natural Resources 2021-08-19 3:34 pm By Miklos Bolza

US-based chemical and materials technology company Cytec Industries has won its Federal Court challenge to a mining patent application by a unit of Ecolab, with the court finding the claims in the patent lacked support and sufficient disclosure.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Caffitaly wins reversal of invalidity ruling on coffee pod patent
Intellectual Property 2021-07-01 12:52 pm By Miklos Bolza

Coffee capsule machine manufacturer Caffitaly has saved one of its coffee pod patents from a finding of invalidity, in a partially successful appeal of a ruling that stripped three of its patents from the Australian register.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Janssen triumphs again in battle to protect HIV drug patents
Intellectual Property 2021-05-24 10:24 am By Cat Fredenburgh

Juno Pharmaceuticals has backed away from its plans to launch a generic version of HIV drug Prezista in Australia after being hit with a patent lawsuit by Janssen, becoming the second generic drug maker to capitulate to the Johnson & Johnson-owned company’s demands.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Pharmacor takes aim at Novartis patents for MS drug Gilenya
Intellectual Property 2021-05-05 11:31 am By Cat Fredenburgh

Generic drug company Pharmacor has fired back in a patent lawsuit by Novartis, filing a cross-claim seeking to invalidate the Swiss drug giant’s patents for its blockbuster MS drug Gilenya.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Sydney Opera House says China trade group copied trade mark in bad faith
Intellectual Property 2021-04-14 1:00 pm By Miklos Bolza

A trade mark application by a China Australia trade association contains an “identical copy” of the Sydney Opera House’s sail design, the trust behind the iconic landmark has claimed as it seeks revocation of the mark on the grounds of bad faith.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Novartis wins injunction to stop generic version of blockbuster MS drug, for now
Intellectual Property 2021-04-12 2:51 pm By Cindy Cameronne

Swiss drug giant Novartis has secured an injunction temporarily blocking drug maker Pharmacor from launching a generic version of the company’s top-selling MS drug Gilenya in Australia.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Patent attorneys who jumped ship hit back in Pizzeys client poaching lawsuit
Intellectual Property 2021-02-24 9:49 pm By Spencer Fowler Steen

Two patent attorneys being sued by boutique IP firm Pizzeys Patent and Trade Mark Attorneys have hit back against claims they misused confidential information to poach clients, arguing the terms of the non-compete restraint in their employment contracts were “unclear”, “unreasonable” and “unenforceable”.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Patent attorneys lured lucrative US law firm clients from IP boutique, new suit claims
Intellectual Property 2020-12-16 2:38 pm By Christine Caulfield

Two patent attorneys who resigned from Pizzeys Patent and Trade Mark Attorneys to launch a competing business performed work for clients of the boutique IP firm a year after they jumped ship, in breach of their employment contracts, a lawsuit claims.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Sydney Opera House fights China group’s trade mark
Intellectual Property 2020-12-04 12:45 pm By Miklos Bolza

The Sydney Opera House is challenging a ruling that denied its opposition to a trade mark application filed by a China-Australia trade association that featured an image of the opera house sails together with the Great Wall of China.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?